These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8539552)

  • 41. [Toxoplasmosis in pregnancy. Comments on the contributions by T. Beringer and T. Krause, W. Straube, S. Wiersbitzky, V. Hitz, A. Kewitsch].
    Petersen EE
    Geburtshilfe Frauenheilkd; 1993 Sep; 53(9):648. PubMed ID: 8224727
    [No Abstract]   [Full Text] [Related]  

  • 42. No. 285-Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment.
    Paquet C; Yudin MH
    J Obstet Gynaecol Can; 2018 Aug; 40(8):e687-e693. PubMed ID: 30103893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia.
    Gallego-Marín C; Henao AC; Gómez-Marín JE
    J Trop Pediatr; 2006 Apr; 52(2):107-12. PubMed ID: 16014760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening methods for congenital toxoplasma and risk of disease.
    Lynfield R; Hsu HW; Guerina NG
    Lancet; 1999 Jun; 353(9168):1899-900. PubMed ID: 10371564
    [No Abstract]   [Full Text] [Related]  

  • 45. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system.
    Villena I; Ancelle T; Delmas C; Garcia P; Brezin AP; Thulliez P; Wallon M; King L; Goulet V;
    Euro Surveill; 2010 Jun; 15(25):. PubMed ID: 20587361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The rates of seropositivity and seroconversion of toxoplasma infection in pregnant women].
    Doğan K; Kafkaslı A; Karaman U; Atambay M; Karaoğlu L; Colak C
    Mikrobiyol Bul; 2012 Apr; 46(2):290-4. PubMed ID: 22639318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Toxoplasma infestation: prevalence, risk of congenital infection and development in Geneva from 1973 to 1987].
    Bornand JE; Piguet JD
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):21-9. PubMed ID: 1990419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.
    Pappas G; Roussos N; Falagas ME
    Int J Parasitol; 2009 Oct; 39(12):1385-94. PubMed ID: 19433092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study.
    Lange AE; Thyrian JR; Wetzka S; Flessa S; Hoffmann W; Zygmunt M; Fusch C; Lode HN; Heckmann M
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):197. PubMed ID: 27473047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of congenital toxoplasmosis in Austria.
    Aspöck H
    Arch Pediatr; 2003 Feb; 10 Suppl 1():16-7. PubMed ID: 12802957
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening programme for congenital toxoplasmosis in France.
    Thulliez P
    Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of toxoplasmosis during pregnancy--an epidemiologic survey over 22 consecutive years.
    Breugelmans M; Naessens A; Foulon W
    J Perinat Med; 2004; 32(3):211-4. PubMed ID: 15188792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxoplasmosis prevention knowledge among pregnant women in Minnesota.
    Ogunmodede F; Scheftel J; Jones JL; Lynfield R
    Minn Med; 2005 Feb; 88(2):32-4. PubMed ID: 17886796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of Toxoplasma gondii infection during pregnancy.
    Montoya JG; Remington JS
    Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands.
    Conyn-van Spaedonck MA; van Knapen F
    Scand J Infect Dis Suppl; 1992; 84():51-8. PubMed ID: 1290075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw].
    Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A
    Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
    Dunn D; Wallon M; Peyron F; Petersen E; Peckham C; Gilbert R
    Lancet; 1999 May; 353(9167):1829-33. PubMed ID: 10359407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal screening for congenital toxoplasmosis in Denmark: presentation of the design of a prospective study.
    Lebech M; Petersen E
    Scand J Infect Dis Suppl; 1992; 84():75-9. PubMed ID: 1290080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [How can the cost of screening for toxoplasmosis during pregnancy be reduced?].
    Ancelle T; Yera H; Talabani H; Lebuisson A; Thulliez P; Dupouy-Camet J
    Rev Epidemiol Sante Publique; 2009 Dec; 57(6):411-7. PubMed ID: 19932576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Congenital toxoplasmosis in the Poznan region].
    Pawłowski Z; Mrozewicz B; Kacprzak E; Pisarski T; Szczapa J; Rybakowski L; Tomaszewski S; Swiecicka-Konarska T; Rokossowski H; Moczko J
    Ginekol Pol; 1994 Aug; 65(8):409-12. PubMed ID: 7721146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.